Navigation Links
China Biopharma, Inc. Announces New Plan of Operation
Date:11/20/2007

HANGZHOU, China, Nov. 20 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) today announced its new plan of operation to take closer control and to better improve its current operation results. The company also plans to move away from the increasingly competitive and low margin vaccine business, and to enter new specialty pharmaceutical products.

"We plan to take more control on the available cash in out subsidiaries and move into higher market potential and higher margin specialty pharmaceutical products," says Peter Wang, CEO and Chairman of Board. "And we are negotiating with a few global vaccine manufacturers now for carrying their higher margin products, in order to avoid direct competitions with other manufacturers."

Recent changes in vaccine sectors have resulted in more vaccine manufacturers entering into low margin vaccine business such as flu vaccine, thus creating severe competition among, and squeezed profit margin of, vaccine distributors such as China Biopharma. Besides moving away from the low margin vaccine business, the company also starts to enter specialty pharmaceutical products such as the recently released anti-viral products.

China Biopharma has most of its operation in China. Working to take direct control on subsidiaries' operation and financial management, the company plans to increase its shareholding in China Zhejiang Tianyuan Biotech Co., Ltd., and eventually to have 100% control and ownership in this joint venture. With internally available resources, there would be no need to raise additional capital to complete the transactions. This is expected to improve current performance and increase operation stability.

"This new direction is expected to preserve available cash position and give us more operation flexibility," says Chunhui Shu, the new interim Chief Financial Officer. "In view of improvement and progress on our current operation results, we have made this plan to take more e
'/>"/>

SOURCE China Biopharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... 11 EntreMed, Inc. (Nasdaq: ENMD ... in royalty revenue from sales of Thalomid® during ... of $3.3 million. In addition, the Company ... revenue for fiscal 2009. The difference in ... will be reflected in the fourth quarter financial ...
(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...
(Date:12/11/2009)... December 11 Algeta ASA (OSE: ... first clinical center in the,US, the Tulane ... patients,in the phase III clinical study of ... hormone-refractory) prostate cancer,(CRPC) that has metastasized to ... The ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Amount of gene surplus determines severity of mental retardation in males 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Extension Builds on Existing Brand Strength and Pediatric ... ... Focus, PLYMOUTH MEETING, Pa., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone ... Sunstone (Tangshan) Pharmaceutical Co., Ltd.,("Sunstone"), its wholly-owned subsidiary, has received ...
... FOUR.OB) today announced it has appointed FBI Supervising Special Agent (Ret.) Dr. ... , ... NEW YORK (Business Wire EON) August 18, 2008 -- ... Federal Bureau of Investigation. Dr. Philip Hayden has spent years involved in ...
... SHANGHAI, China, Aug. 18 /PRNewswire-FirstCall/,-- MicuRx ... next-generation antibiotics, today announced the nomination ... development candidate. MRX-I is an,antibacterial molecule ... Staphylococcus aureus (MRSA).,Simultaneously, the company expanded ...
Other Biology Technology:BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 2BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 3BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 4 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China 2
(Date:12/15/2009)... San Diego, California, has been awarded an accreditation ... on results of a recent onsite inspection. ... this national recognition and congratulated for the "excellence ... GenWay Clinical Laboratory is one of nearly 7,000 ... Program, begun in the early 1960s, is recognized ...
(Date:12/15/2009)... researchers found the fossil remains of a whale, 4.5 million ... the first time, the results of the decay and fossilisation ... possibly a baleen whale from the Mysticeti group. , This ... of a whale from the Lower Pliocene (five million years ... the first time that the results of the processes of ...
(Date:12/15/2009)... standard laboratory model organism, but there are currently ... blood and blood-forming tissues in this species. ... laboratory resources from Cold Spring Harbor Laboratory Press ... features step-by-step protocols for the preparation, enumeration, and ... other hematopoietic tissues in the mouse. The ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2IPC The Hospitalist Company Inc to Report Second Quarter 2009 Results 52237 1IPC The Hospitalist Company Inc to Report Second Quarter 2009 Results 52237 2BioNeutrals Ygiene 28TM 29 Hospital Grade Achieves a 100 25 Total Kill 28Pass 29 Against the Life Threatening Clostridium Difficile 28C diff 29 Spor 13123 1BioNeutrals Ygiene 28TM 29 Hospital Grade Achieves a 100 25 Total Kill 28Pass 29 Against the Life Threatening Clostridium Difficile 28C diff 29 Spor 13123 2BioNeutrals Ygiene 28TM 29 Hospital Grade Achieves a 100 25 Total Kill 28Pass 29 Against the Life Threatening Clostridium Difficile 28C diff 29 Spor 13123 3My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 1My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 2My InnerView and UW Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 52230 3
... The asteroid presumed to have wiped out the dinosaurs ... in the Earth,s crust liquefied, rocketed skyward, and formed ... from the U.S., U.K., Italy, and New Zealand in ... geologists as carbon cenospheres, cannot be formed through the ...
... role to play in the fate of potentially dangerous depleted ... to a new report in the May 6th issue of ... researchers found evidence that fungi can lock depleted uranium into ... its way into plants, animals, or the water supply. , ...
... currently a grave concern for governments and health organisations around ... bird flu strains, such as H5N1, to develop the ability ... the spread of the virus are badly needed. Now one ... the machinery of infected cells has been laid bare by ...
Other Biology News:65-million-year-old asteroid impact triggered a global hail of carbon beads 265-million-year-old asteroid impact triggered a global hail of carbon beads 3Fungi have a hand in depleted uranium's environmental fate 2Getting wise to the influenza virus' tricks 2
...
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
... mixed TAMRA isomers are predominantly used for ... preferred for labeling peptides and nucleotides because ... that is often required in the conjugation ... 6-TAMRA for labeling peptides and proteins. 6-TAMRA ...
Biology Products: